An in vitro study of alginate oligomer therapies on oral biofilms

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

StandardStandard

An in vitro study of alginate oligomer therapies on oral biofilms. / Roberts, Jessica; Khan, S; Emanuel, C et al.
Yn: Journal of Dentistry, Cyfrol 41, Rhif 10, 10.2013, t. 892-9.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Roberts, J, Khan, S, Emanuel, C, Powell, LC, Pritchard, MF, Onsøyen, E, Myrvold, R, Thomas, DW & Hill, KE 2013, 'An in vitro study of alginate oligomer therapies on oral biofilms', Journal of Dentistry, cyfrol. 41, rhif 10, tt. 892-9. https://doi.org/10.1016/j.jdent.2013.07.011

APA

Roberts, J., Khan, S., Emanuel, C., Powell, L. C., Pritchard, M. F., Onsøyen, E., Myrvold, R., Thomas, D. W., & Hill, K. E. (2013). An in vitro study of alginate oligomer therapies on oral biofilms. Journal of Dentistry, 41(10), 892-9. https://doi.org/10.1016/j.jdent.2013.07.011

CBE

Roberts J, Khan S, Emanuel C, Powell LC, Pritchard MF, Onsøyen E, Myrvold R, Thomas DW, Hill KE. 2013. An in vitro study of alginate oligomer therapies on oral biofilms. Journal of Dentistry. 41(10):892-9. https://doi.org/10.1016/j.jdent.2013.07.011

MLA

VancouverVancouver

Roberts J, Khan S, Emanuel C, Powell LC, Pritchard MF, Onsøyen E et al. An in vitro study of alginate oligomer therapies on oral biofilms. Journal of Dentistry. 2013 Hyd;41(10):892-9. doi: 10.1016/j.jdent.2013.07.011

Author

Roberts, Jessica ; Khan, S ; Emanuel, C et al. / An in vitro study of alginate oligomer therapies on oral biofilms. Yn: Journal of Dentistry. 2013 ; Cyfrol 41, Rhif 10. tt. 892-9.

RIS

TY - JOUR

T1 - An in vitro study of alginate oligomer therapies on oral biofilms

AU - Roberts, Jessica

AU - Khan, S

AU - Emanuel, C

AU - Powell, L C

AU - Pritchard, M F

AU - Onsøyen, E

AU - Myrvold, R

AU - Thomas, D W

AU - Hill, K E

N1 - Copyright © 2013 Elsevier Ltd. All rights reserved.

PY - 2013/10

Y1 - 2013/10

N2 - OBJECTIVES: The in vitro effect of a novel, oligosaccharide nanomedicine OligoG against oral pathogen-related biofilms, both alone and in the presence of the conventional anti-bacterial agent triclosan, was evaluated.METHODS: The effect of OligoG±triclosan was assessed against established Streptococcus mutans and Porphyromonas gingivalis biofilms by bacterial counts and image analysis using LIVE/DEAD(®) staining and atomic force microscopy (AFM). The effect of triclosan and OligoG surface pre-treatments on bacterial attachment to titanium and polymethylmethacrylate was also studied.RESULTS: OligoG potentiated the antimicrobial effect of triclosan, particularly when used in combination at 0.3% against S. mutans grown in artificial saliva. OligoG was less effective against established P. gingivalis biofilms. However, attachment of P. gingivalis, to titanium in particular, was significantly reduced after surface pre-treatment with OligoG and triclosan at 0.01% when compared to controls. Light microscopy and AFM showed that OligoG was biocidal to P. gingivalis, but not S. mutans.CONCLUSIONS: OligoG and triclosan when used in combination produced an enhanced antimicrobial effect against two important oral pathogens and reduced bacterial attachment to dental materials such as titanium, even at reduced triclosan concentrations. Whilst the use of triclosan against oral bacteria has been widely documented, its synergistic use with OligoG described here, has not previously been reported. The use of lower concentrations of triclosan, if used in combination therapy with OligoG, could have environmental benefits.CLINICAL IMPORTANCE: The potentiation of antimicrobial agents by naturally occurring oligomers such as OligoG may represent a novel, safe adjunct to conventional oral hygiene and periodontal therapy. The ability of OligoG to inhibit the growth and impair bacterial adherence highlights its potential in the management of peri-implantitis.

AB - OBJECTIVES: The in vitro effect of a novel, oligosaccharide nanomedicine OligoG against oral pathogen-related biofilms, both alone and in the presence of the conventional anti-bacterial agent triclosan, was evaluated.METHODS: The effect of OligoG±triclosan was assessed against established Streptococcus mutans and Porphyromonas gingivalis biofilms by bacterial counts and image analysis using LIVE/DEAD(®) staining and atomic force microscopy (AFM). The effect of triclosan and OligoG surface pre-treatments on bacterial attachment to titanium and polymethylmethacrylate was also studied.RESULTS: OligoG potentiated the antimicrobial effect of triclosan, particularly when used in combination at 0.3% against S. mutans grown in artificial saliva. OligoG was less effective against established P. gingivalis biofilms. However, attachment of P. gingivalis, to titanium in particular, was significantly reduced after surface pre-treatment with OligoG and triclosan at 0.01% when compared to controls. Light microscopy and AFM showed that OligoG was biocidal to P. gingivalis, but not S. mutans.CONCLUSIONS: OligoG and triclosan when used in combination produced an enhanced antimicrobial effect against two important oral pathogens and reduced bacterial attachment to dental materials such as titanium, even at reduced triclosan concentrations. Whilst the use of triclosan against oral bacteria has been widely documented, its synergistic use with OligoG described here, has not previously been reported. The use of lower concentrations of triclosan, if used in combination therapy with OligoG, could have environmental benefits.CLINICAL IMPORTANCE: The potentiation of antimicrobial agents by naturally occurring oligomers such as OligoG may represent a novel, safe adjunct to conventional oral hygiene and periodontal therapy. The ability of OligoG to inhibit the growth and impair bacterial adherence highlights its potential in the management of peri-implantitis.

KW - Alginates

KW - Anti-Bacterial Agents

KW - Bacterial Adhesion

KW - Bacterial Load

KW - Bacteriological Techniques

KW - Biofilms

KW - Dental Materials

KW - Drug Combinations

KW - Drug Synergism

KW - Humans

KW - Materials Testing

KW - Microbial Viability

KW - Microscopy, Atomic Force

KW - Microscopy, Fluorescence

KW - Mouth

KW - Oligosaccharides

KW - Polymethyl Methacrylate

KW - Porphyromonas gingivalis

KW - Saliva, Artificial

KW - Streptococcus mutans

KW - Titanium

KW - Triclosan

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1016/j.jdent.2013.07.011

DO - 10.1016/j.jdent.2013.07.011

M3 - Article

C2 - 23907083

VL - 41

SP - 892

EP - 899

JO - Journal of Dentistry

JF - Journal of Dentistry

SN - 0300-5712

IS - 10

ER -